 Connection
Manojkumar Bupathi to Antibodies, Monoclonal
This is a "connection" page, showing publications Manojkumar Bupathi has written about Antibodies, Monoclonal.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.170 |
|
|
|
-
Milowsky MI, O'Donnell PH, Hoimes CJ, Petrylak DP, Flaig TW, Moon HH, Friedlander TW, Mar N, McKay RR, Srinivas S, Gravis G, Ramamurthy C, Bupathi M, Bracarda S, Wright P, Hepp Z, Carret AS, Yu Y, Dillon R, Kataria R, Beaumont JL, Purnajo I, Rosenberg JE. Patient-Reported Outcomes in Patients With Advanced Urothelial Cancer Who Are Ineligible for Cisplatin and Treated With First-Line Enfortumab Vedotin Alone or With Pembrolizumab. J Clin Oncol. 2024 04 20; 42(12):1403-1414.
Score: 0.120
-
Antonelli M, Bupathi M, Janakiram M, Hergenroeder P, Khan MA. Acquired erythrocytosis upon treatment with infliximab for ankylosing spondylitis. J Rheumatol. 2011 Mar; 38(3):581-3.
Score: 0.049
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|